Loading…
Acromegaly caused by a GHRH-producing pancreatic neuroendocrine tumor: a rare manifestation of MEN1 syndrome
Summary Multiple endocrine neoplasia type 1 NM_001370259.2(MEN1):c.466G>C(p.Gly156Arg) is characterized by tumors of various endocrine organs. We report on a rare, growth hormone-releasing hormone (GHRH)-releasing pancreatic tumor in a MEN1 patient with a long-term follow-up after surgery. A 22-y...
Saved in:
Published in: | Endocrinology, diabetes & metabolism case reports diabetes & metabolism case reports, 2022-02, Vol.2022 (1), p.1-5 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-b489t-6b8da35d8022fc4240c88cb14c58919aa2190ab3e9500becd76c98c7723dd39f3 |
---|---|
cites | cdi_FETCH-LOGICAL-b489t-6b8da35d8022fc4240c88cb14c58919aa2190ab3e9500becd76c98c7723dd39f3 |
container_end_page | 5 |
container_issue | 1 |
container_start_page | 1 |
container_title | Endocrinology, diabetes & metabolism case reports |
container_volume | 2022 |
creator | Koivikko, Minna Ebeling, Tapani Mäkinen, Markus Leppäluoto, Juhani Raappana, Antti Ahtiainen, Petteri Salmela, Pasi |
description | Summary Multiple endocrine neoplasia type 1 NM_001370259.2(MEN1):c.466G>C(p.Gly156Arg) is characterized by tumors of various endocrine organs. We report on a rare, growth hormone-releasing hormone (GHRH)-releasing pancreatic tumor in a MEN1 patient with a long-term follow-up after surgery. A 22-year-old male with MEN1 syndrome, primary hyperparathyroidism and an acromegalic habitus was observed to have a pancreatic tumor on abdominal CT scanning, growth hormone (GH) and insulin-like growth factor 1 (IGF1) were elevated and plasma GHRH was exceptionally high. GHRH and GH were measured before the treatment and were followed during the study. During octreotide treatment, IGF1 normalized and the GH curve was near normal. After surgical treatment of primary hyperparathyroidism, a pancreatic tail tumor was enucleated. The tumor cells were positive for GHRH antibody staining. After the operation, acromegaly was cured as judged by laboratory tests. No reactivation of acromegaly has been seen during a 20-year follow-up. In conclusion, an ectopic GHRH-producing, pancreatic endocrine neoplasia may represent a rare manifestation of MEN1 syndrome. Learning points Clinical suspicion is in a key position in detecting acromegaly. Remember genetic disorders with young individuals having primary hyperparathyroidism. Consider multiple endocrine neoplasia type 1 syndrome when a person has several endocrine neoplasia. Acromegaly may be of ectopic origin with patients showing no abnormalities in radiological imaging of the pituitary gland. |
doi_str_mv | 10.1530/EDM-21-0079 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_d21c70b53df44a2784d0774907d18994</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_d21c70b53df44a2784d0774907d18994</doaj_id><sourcerecordid>2632799267</sourcerecordid><originalsourceid>FETCH-LOGICAL-b489t-6b8da35d8022fc4240c88cb14c58919aa2190ab3e9500becd76c98c7723dd39f3</originalsourceid><addsrcrecordid>eNp9kc9rFDEUxwdRbKk9eZccBZman5PEg1Dq2i20CqLn8CbJrCkzyZrMCPvfm-22pb14Ssj75PNe8m2atwSfEcHwx9WXm5aSFmOpXzTHFAvaYiHZyyf7o-a0lFuMMcGCdYq9bo6YIFp3vDtuxnOb0-Q3MO6QhaV4h_odAnS5_rFutzm5xYa4QVuINnuYg0XRLzn56JLNIXo0L1PKn-qNDNmjCWIYfJkrmSJKA7pZfSOo7KLbd3nTvBpgLP70fj1pfn1d_bxYt9ffL68uzq_bnis9t12vHDDhFKZ0sJxybJWyPeFWKE00ACUaQ8-8Fhj33jrZWa2slJQ5x_TATpqrg9cluDXbHCbIO5MgmLuDlDcGcn3L6I2jxErcC-YGzoFKxR2WkmssHVFa8-r6fHBtl37yzvo4ZxifSZ9XYvhtNumvUUpLcSd4fy_I6c9S_8ZMoVg_jhB9WoqhHaNSa9rJin44oDWTUrIfHtsQbPZxmxq3ocTs4670u6eTPbIP4VaAHIA-pGJDnS8MwcJ_pf8A6CK1tw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2632799267</pqid></control><display><type>article</type><title>Acromegaly caused by a GHRH-producing pancreatic neuroendocrine tumor: a rare manifestation of MEN1 syndrome</title><source>PubMed Central Free</source><creator>Koivikko, Minna ; Ebeling, Tapani ; Mäkinen, Markus ; Leppäluoto, Juhani ; Raappana, Antti ; Ahtiainen, Petteri ; Salmela, Pasi</creator><creatorcontrib>Koivikko, Minna ; Ebeling, Tapani ; Mäkinen, Markus ; Leppäluoto, Juhani ; Raappana, Antti ; Ahtiainen, Petteri ; Salmela, Pasi</creatorcontrib><description>Summary Multiple endocrine neoplasia type 1 NM_001370259.2(MEN1):c.466G>C(p.Gly156Arg) is characterized by tumors of various endocrine organs. We report on a rare, growth hormone-releasing hormone (GHRH)-releasing pancreatic tumor in a MEN1 patient with a long-term follow-up after surgery. A 22-year-old male with MEN1 syndrome, primary hyperparathyroidism and an acromegalic habitus was observed to have a pancreatic tumor on abdominal CT scanning, growth hormone (GH) and insulin-like growth factor 1 (IGF1) were elevated and plasma GHRH was exceptionally high. GHRH and GH were measured before the treatment and were followed during the study. During octreotide treatment, IGF1 normalized and the GH curve was near normal. After surgical treatment of primary hyperparathyroidism, a pancreatic tail tumor was enucleated. The tumor cells were positive for GHRH antibody staining. After the operation, acromegaly was cured as judged by laboratory tests. No reactivation of acromegaly has been seen during a 20-year follow-up. In conclusion, an ectopic GHRH-producing, pancreatic endocrine neoplasia may represent a rare manifestation of MEN1 syndrome. Learning points Clinical suspicion is in a key position in detecting acromegaly. Remember genetic disorders with young individuals having primary hyperparathyroidism. Consider multiple endocrine neoplasia type 1 syndrome when a person has several endocrine neoplasia. Acromegaly may be of ectopic origin with patients showing no abnormalities in radiological imaging of the pituitary gland.</description><identifier>ISSN: 2052-0573</identifier><identifier>EISSN: 2052-0573</identifier><identifier>DOI: 10.1530/EDM-21-0079</identifier><identifier>PMID: 35199646</identifier><language>eng</language><publisher>England: Bioscientifica Ltd</publisher><subject>Adult ; Finland ; Gastroenterology ; General Practice ; Genetics ; Insight into Disease Pathogenesis or Mechanism of Therapy ; Male ; Neuroendocrinology ; Pancreas ; Tumours and Neoplasia ; White</subject><ispartof>Endocrinology, diabetes & metabolism case reports, 2022-02, Vol.2022 (1), p.1-5</ispartof><rights>The authors</rights><rights>The authors 2022 The authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b489t-6b8da35d8022fc4240c88cb14c58919aa2190ab3e9500becd76c98c7723dd39f3</citedby><cites>FETCH-LOGICAL-b489t-6b8da35d8022fc4240c88cb14c58919aa2190ab3e9500becd76c98c7723dd39f3</cites><orcidid>0000-0001-7227-966X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897594/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897594/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35199646$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Koivikko, Minna</creatorcontrib><creatorcontrib>Ebeling, Tapani</creatorcontrib><creatorcontrib>Mäkinen, Markus</creatorcontrib><creatorcontrib>Leppäluoto, Juhani</creatorcontrib><creatorcontrib>Raappana, Antti</creatorcontrib><creatorcontrib>Ahtiainen, Petteri</creatorcontrib><creatorcontrib>Salmela, Pasi</creatorcontrib><title>Acromegaly caused by a GHRH-producing pancreatic neuroendocrine tumor: a rare manifestation of MEN1 syndrome</title><title>Endocrinology, diabetes & metabolism case reports</title><addtitle>Endocrinol Diabetes Metab Case Rep</addtitle><description>Summary Multiple endocrine neoplasia type 1 NM_001370259.2(MEN1):c.466G>C(p.Gly156Arg) is characterized by tumors of various endocrine organs. We report on a rare, growth hormone-releasing hormone (GHRH)-releasing pancreatic tumor in a MEN1 patient with a long-term follow-up after surgery. A 22-year-old male with MEN1 syndrome, primary hyperparathyroidism and an acromegalic habitus was observed to have a pancreatic tumor on abdominal CT scanning, growth hormone (GH) and insulin-like growth factor 1 (IGF1) were elevated and plasma GHRH was exceptionally high. GHRH and GH were measured before the treatment and were followed during the study. During octreotide treatment, IGF1 normalized and the GH curve was near normal. After surgical treatment of primary hyperparathyroidism, a pancreatic tail tumor was enucleated. The tumor cells were positive for GHRH antibody staining. After the operation, acromegaly was cured as judged by laboratory tests. No reactivation of acromegaly has been seen during a 20-year follow-up. In conclusion, an ectopic GHRH-producing, pancreatic endocrine neoplasia may represent a rare manifestation of MEN1 syndrome. Learning points Clinical suspicion is in a key position in detecting acromegaly. Remember genetic disorders with young individuals having primary hyperparathyroidism. Consider multiple endocrine neoplasia type 1 syndrome when a person has several endocrine neoplasia. Acromegaly may be of ectopic origin with patients showing no abnormalities in radiological imaging of the pituitary gland.</description><subject>Adult</subject><subject>Finland</subject><subject>Gastroenterology</subject><subject>General Practice</subject><subject>Genetics</subject><subject>Insight into Disease Pathogenesis or Mechanism of Therapy</subject><subject>Male</subject><subject>Neuroendocrinology</subject><subject>Pancreas</subject><subject>Tumours and Neoplasia</subject><subject>White</subject><issn>2052-0573</issn><issn>2052-0573</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9kc9rFDEUxwdRbKk9eZccBZman5PEg1Dq2i20CqLn8CbJrCkzyZrMCPvfm-22pb14Ssj75PNe8m2atwSfEcHwx9WXm5aSFmOpXzTHFAvaYiHZyyf7o-a0lFuMMcGCdYq9bo6YIFp3vDtuxnOb0-Q3MO6QhaV4h_odAnS5_rFutzm5xYa4QVuINnuYg0XRLzn56JLNIXo0L1PKn-qNDNmjCWIYfJkrmSJKA7pZfSOo7KLbd3nTvBpgLP70fj1pfn1d_bxYt9ffL68uzq_bnis9t12vHDDhFKZ0sJxybJWyPeFWKE00ACUaQ8-8Fhj33jrZWa2slJQ5x_TATpqrg9cluDXbHCbIO5MgmLuDlDcGcn3L6I2jxErcC-YGzoFKxR2WkmssHVFa8-r6fHBtl37yzvo4ZxifSZ9XYvhtNumvUUpLcSd4fy_I6c9S_8ZMoVg_jhB9WoqhHaNSa9rJin44oDWTUrIfHtsQbPZxmxq3ocTs4670u6eTPbIP4VaAHIA-pGJDnS8MwcJ_pf8A6CK1tw</recordid><startdate>20220201</startdate><enddate>20220201</enddate><creator>Koivikko, Minna</creator><creator>Ebeling, Tapani</creator><creator>Mäkinen, Markus</creator><creator>Leppäluoto, Juhani</creator><creator>Raappana, Antti</creator><creator>Ahtiainen, Petteri</creator><creator>Salmela, Pasi</creator><general>Bioscientifica Ltd</general><general>Bioscientifica</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-7227-966X</orcidid></search><sort><creationdate>20220201</creationdate><title>Acromegaly caused by a GHRH-producing pancreatic neuroendocrine tumor: a rare manifestation of MEN1 syndrome</title><author>Koivikko, Minna ; Ebeling, Tapani ; Mäkinen, Markus ; Leppäluoto, Juhani ; Raappana, Antti ; Ahtiainen, Petteri ; Salmela, Pasi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b489t-6b8da35d8022fc4240c88cb14c58919aa2190ab3e9500becd76c98c7723dd39f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adult</topic><topic>Finland</topic><topic>Gastroenterology</topic><topic>General Practice</topic><topic>Genetics</topic><topic>Insight into Disease Pathogenesis or Mechanism of Therapy</topic><topic>Male</topic><topic>Neuroendocrinology</topic><topic>Pancreas</topic><topic>Tumours and Neoplasia</topic><topic>White</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Koivikko, Minna</creatorcontrib><creatorcontrib>Ebeling, Tapani</creatorcontrib><creatorcontrib>Mäkinen, Markus</creatorcontrib><creatorcontrib>Leppäluoto, Juhani</creatorcontrib><creatorcontrib>Raappana, Antti</creatorcontrib><creatorcontrib>Ahtiainen, Petteri</creatorcontrib><creatorcontrib>Salmela, Pasi</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Endocrinology, diabetes & metabolism case reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Koivikko, Minna</au><au>Ebeling, Tapani</au><au>Mäkinen, Markus</au><au>Leppäluoto, Juhani</au><au>Raappana, Antti</au><au>Ahtiainen, Petteri</au><au>Salmela, Pasi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Acromegaly caused by a GHRH-producing pancreatic neuroendocrine tumor: a rare manifestation of MEN1 syndrome</atitle><jtitle>Endocrinology, diabetes & metabolism case reports</jtitle><addtitle>Endocrinol Diabetes Metab Case Rep</addtitle><date>2022-02-01</date><risdate>2022</risdate><volume>2022</volume><issue>1</issue><spage>1</spage><epage>5</epage><pages>1-5</pages><issn>2052-0573</issn><eissn>2052-0573</eissn><abstract>Summary Multiple endocrine neoplasia type 1 NM_001370259.2(MEN1):c.466G>C(p.Gly156Arg) is characterized by tumors of various endocrine organs. We report on a rare, growth hormone-releasing hormone (GHRH)-releasing pancreatic tumor in a MEN1 patient with a long-term follow-up after surgery. A 22-year-old male with MEN1 syndrome, primary hyperparathyroidism and an acromegalic habitus was observed to have a pancreatic tumor on abdominal CT scanning, growth hormone (GH) and insulin-like growth factor 1 (IGF1) were elevated and plasma GHRH was exceptionally high. GHRH and GH were measured before the treatment and were followed during the study. During octreotide treatment, IGF1 normalized and the GH curve was near normal. After surgical treatment of primary hyperparathyroidism, a pancreatic tail tumor was enucleated. The tumor cells were positive for GHRH antibody staining. After the operation, acromegaly was cured as judged by laboratory tests. No reactivation of acromegaly has been seen during a 20-year follow-up. In conclusion, an ectopic GHRH-producing, pancreatic endocrine neoplasia may represent a rare manifestation of MEN1 syndrome. Learning points Clinical suspicion is in a key position in detecting acromegaly. Remember genetic disorders with young individuals having primary hyperparathyroidism. Consider multiple endocrine neoplasia type 1 syndrome when a person has several endocrine neoplasia. Acromegaly may be of ectopic origin with patients showing no abnormalities in radiological imaging of the pituitary gland.</abstract><cop>England</cop><pub>Bioscientifica Ltd</pub><pmid>35199646</pmid><doi>10.1530/EDM-21-0079</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0001-7227-966X</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2052-0573 |
ispartof | Endocrinology, diabetes & metabolism case reports, 2022-02, Vol.2022 (1), p.1-5 |
issn | 2052-0573 2052-0573 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_d21c70b53df44a2784d0774907d18994 |
source | PubMed Central Free |
subjects | Adult Finland Gastroenterology General Practice Genetics Insight into Disease Pathogenesis or Mechanism of Therapy Male Neuroendocrinology Pancreas Tumours and Neoplasia White |
title | Acromegaly caused by a GHRH-producing pancreatic neuroendocrine tumor: a rare manifestation of MEN1 syndrome |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T17%3A28%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Acromegaly%20caused%20by%20a%20GHRH-producing%20pancreatic%20neuroendocrine%20tumor:%20a%20rare%20manifestation%20of%20MEN1%20syndrome&rft.jtitle=Endocrinology,%20diabetes%20&%20metabolism%20case%20reports&rft.au=Koivikko,%20Minna&rft.date=2022-02-01&rft.volume=2022&rft.issue=1&rft.spage=1&rft.epage=5&rft.pages=1-5&rft.issn=2052-0573&rft.eissn=2052-0573&rft_id=info:doi/10.1530/EDM-21-0079&rft_dat=%3Cproquest_doaj_%3E2632799267%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b489t-6b8da35d8022fc4240c88cb14c58919aa2190ab3e9500becd76c98c7723dd39f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2632799267&rft_id=info:pmid/35199646&rfr_iscdi=true |